Inflammatory Pseudotumor After Total Hip Arthroplasty‐An Increasingly Recognized Complication
Orthopaedic Surgery · 2026-07 · 18 (7) · 1311-1327
DOI: 10.1111/os.70334 ↗At a glance
Übersichtsarbeit in Orthopaedic Surgery, published online on 2026-06-02. Written by Steve T L Pambayi and 8 co-authors. Institution: Department of Orthopedics Surgery, Orthopedics Research Institute, and National Clinical Research Center for Geriatric, West China Hospital, Sichuan …. Major MEDLINE topics: Arthroplasty, Replacement, Hip, Granuloma, Plasma Cell, Hip Prosthesis, Postoperative Complications. 72 references. The full text is freely available (open access, CC BY 4.0). Funded by: West China Hospital Clinical Research Incubation Program, 2023 National Key Research and Development Program of China.
Abstract (original language)
Inflammatory pseudotumor (IP) is an increasingly recognized etiological factor in the failure of total hip arthroplasty (THA). It is a non‐neoplastic, non‐infectious mass encircling a hip prosthesis following arthroplasty and may appear as cystic, solid, or mixed tissue. Although initially associated with metal‐on‐metal (MoM) bearing surfaces, IP formation can also occur with other bearing types. Recognized risk factors include female sex, specific genetic predispositions, MoM bearings, large femoral head size, modular femoral stem designs, elevated metal ion levels, and wear debris from polyethylene components. IP contributes to THA failure through both mechanical and inflammatory mechanisms, often leading to pain, instability, or implant loosening. Diagnosis relies heavily on imaging modalities, including plain radiographs, ultrasound, CT, and MRI with metal artifact reduction sequences (MARS‐MRI), which help delineate the extent and characteristics of IP lesions. A multimodal imaging approach is essential for accurate assessment and surgical planning. Management strategies are guided by clinical presentation and radiographic findings, such as IP size and anatomical location, ranging from close observation in asymptomatic cases to revision surgery in symptomatic or progressive disease. IP is therefore an important, imaging‐detectable cause of THA failure, and awareness of its presentation and diagnostic features is critical for timely intervention and improved patient outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Orthopedics Surgery, Orthopedics Research Institute, and National Clinical Research Center for Geriatric, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Pulmonary and Critical Care Medicine, Division of Pulmonary Diseases, State Key Laboratory of Biotherapy, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan, China.
Funding
- West China Hospital Clinical Research Incubation Program
- 2023 National Key Research and Development Program of China
Cite
APA
Pambayi, S. T. L., Zhao, Z., Peng, H., Xia, R., Zhu, X., Suolang, W., Wang, G., Li, X., & Zeng, Y. (2026). Inflammatory Pseudotumor After Total Hip Arthroplasty‐An Increasingly Recognized Complication. Orthopaedic Surgery, 18(7), 1311-1327. https://doi.org/10.1111/os.70334
Vancouver
Pambayi STL, Zhao Z, Peng H, Xia R, Zhu X, Suolang W, et al. Inflammatory Pseudotumor After Total Hip Arthroplasty‐An Increasingly Recognized Complication. Orthopaedic Surgery. 2026;18(7):1311-1327. doi:10.1111/os.70334
BibTeX
@article{Pambayi2026,
author = {Pambayi, Steve T L and Zhao, Zhi and Peng, Hongjun and Xia, Ruihao and Zhu, Xishan and Suolang, Wangdui and Wang, Gang and Li, Xiaoou and Zeng, Yi},
title = {Inflammatory Pseudotumor After Total Hip Arthroplasty‐An Increasingly Recognized Complication},
journal = {Orthopaedic Surgery},
year = {2026},
volume = {18},
number = {7},
pages = {1311--1327},
doi = {10.1111/os.70334}
}
EUVIMED